These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9430852

  • 1. Urinary transforming growth factor-beta 1 in membranous glomerulonephritis.
    Honkanen E, Teppo AM, Törnroth T, Groop PH, Grönhagen-Riska C.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2562-8. PubMed ID: 9430852
    [Abstract] [Full Text] [Related]

  • 2. Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis.
    Honkanen EO, Teppo AM, Grönhagen-Riska C.
    Kidney Int; 2000 Jun; 57(6):2343-9. PubMed ID: 10844604
    [Abstract] [Full Text] [Related]

  • 3. Urinary transforming growth factor-beta 1 in various types of nephropathy.
    De Muro P, Faedda R, Fresu P, Masala A, Cigni A, Concas G, Mela MG, Satta A, Carcassi A, Sanna GM, Cherchi GM.
    Pharmacol Res; 2004 Mar; 49(3):293-8. PubMed ID: 14726227
    [Abstract] [Full Text] [Related]

  • 4. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
    Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.
    Am J Kidney Dis; 1997 Sep; 30(3):404-12. PubMed ID: 9292570
    [Abstract] [Full Text] [Related]

  • 5. Steroid therapy and urinary transforming growth factor-beta1 in IgA nephropathy.
    Haramaki R, Tamaki K, Fujisawa M, Ikedo H, Haramaki N, Okuda S.
    Am J Kidney Dis; 2001 Dec; 38(6):1191-8. PubMed ID: 11728950
    [Abstract] [Full Text] [Related]

  • 6. Transforming growth factor-beta(1) in the kidney and urine of patients with glomerular disease and proteinuria.
    Goumenos DS, Tsakas S, El Nahas AM, Alexandri S, Oldroyd S, Kalliakmani P, Vlachojannis JG.
    Nephrol Dial Transplant; 2002 Dec; 17(12):2145-52. PubMed ID: 12454225
    [Abstract] [Full Text] [Related]

  • 7. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN, Chebotareva NV, Kozlovskaia LV, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2006 Dec; 78(5):9-14. PubMed ID: 16889042
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urine activity of cathepsin B, collagenase and urine excretion of TGF-beta 1 and fibronectin in membranous glomerulonephritis.
    Senatorski G, Paczek L, Sułowicz W, Gradowska L, Bartłomiejczyk I.
    Res Exp Med (Berl); 1998 Dec; 198(4):199-206. PubMed ID: 9879598
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C, Usui T, Rizza V, Casellato D, Gallieni M, Nangaku M.
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [Abstract] [Full Text] [Related]

  • 12. Urinary transforming growth factor-beta1 excretion in renal allograft recipients during the early post-transplantation period.
    Goumenos DS, Tsakas S, Karavias D, Savidaki I, Karatzas T, Vlachojannis JG.
    Ren Fail; 2003 Jul; 25(4):561-8. PubMed ID: 12911160
    [Abstract] [Full Text] [Related]

  • 13. Increased excretion of urinary transforming growth factor beta in patients with focal glomerular sclerosis.
    Kanai H, Mitsuhashi H, Ono K, Yano S, Naruse T.
    Nephron; 1994 Jul; 66(4):391-5. PubMed ID: 8015640
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical course.
    Honkanen E, von Willebrand E, Koskinen P, Teppo AM, Törnroth T, Ruutu M, Grönhagen-Riska C.
    Am J Kidney Dis; 2003 Dec; 42(6):1139-48. PubMed ID: 14655184
    [Abstract] [Full Text] [Related]

  • 16. Transforming growth factor beta 1 in renal allograft recipients.
    Coupes BM, Newstead CG, Short CD, Brenchley PE.
    Transplantation; 1994 Jun 27; 57(12):1727-31. PubMed ID: 8016876
    [Abstract] [Full Text] [Related]

  • 17. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis.
    Lehto T, Honkanen E, Teppo AM, Meri S.
    Kidney Int; 1995 May 27; 47(5):1403-11. PubMed ID: 7543624
    [Abstract] [Full Text] [Related]

  • 18. Urinary excretion of beta 2-microglobulin predicts renal outcome in patients with idiopathic membranous nephropathy.
    Reichert LJ, Koene RA, Wetzels JF.
    J Am Soc Nephrol; 1995 Dec 27; 6(6):1666-9. PubMed ID: 8749696
    [Abstract] [Full Text] [Related]

  • 19. Urinary amino-terminal propeptide of type III procollagen (PIIINP) as a marker of interstitial fibrosis in renal transplant recipients.
    Teppo AM, Törnroth T, Honkanen E, Grönhagen-Riska C.
    Transplantation; 2003 Jun 27; 75(12):2113-9. PubMed ID: 12829921
    [Abstract] [Full Text] [Related]

  • 20. Urinary IgG excretion as a prognostic factor in idiopathic membranous nephropathy.
    Reichert LJ, Koene RA, Wetzels JF.
    Clin Nephrol; 1997 Aug 27; 48(2):79-84. PubMed ID: 9285143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.